Infliximab vs. Other Biologics: Which Biologic Is Right for You?

What is Infliximab?

Infliximab is a biologic medicine used to treat a wide range of autoimmune and inflammatory conditions, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriasis, and psoriatic arthritis. It works by blocking tumour necrosis factor-alpha (TNF-α), a key protein in the immune system that drives inflammation.

By interrupting this process, infliximab not only helps reduce inflammation and slow disease progression but also improves daily life for patients. For many, this can mean less pain, greater mobility, fewer flare-ups, and an overall better quality of life.

How Infliximab Is Delivered

Infliximab must be given through intravenous infusion therapy in a clinical setting. Administering it directly into the bloodstream allows for precise dosing, rapid absorption, and continuous monitoring by healthcare professionals. Treatments are usually scheduled every six to eight weeks, depending on the patient’s condition and response.

Comparing Infliximab with Other Biologics

While infliximab is highly effective, it is not the only biologic available. Other biologics may be prescribed depending on the patient’s diagnosis, disease severity, and treatment response. Key comparisons include:

  • Adalimumab (Humira) – Delivered via injection rather than infusion, making it more convenient for home use. Like infliximab, it targets TNF-α.
  • Etanercept (Enbrel) – Another TNF inhibitor given by injection, often used for arthritis and psoriasis.
  • Ocrelizumab (Ocrevus) – A monoclonal antibody used for multiple sclerosis, delivered by infusion therapy.
  • Natalizumab (Tysabri) – Commonly prescribed for Crohn’s disease and multiple sclerosis, also given intravenously.
  • Ustekinumab (Stelara) – Works on different immune pathways and can be given as an infusion or injection, depending on the condition.

Choosing the Right Biologic for You

Patient experiences and needs vary from one individual to another and selecting the most appropriate biologic depends on several factors, including

  • Your specific condition (Crohn’s, RA, MS, etc.)
  • How severe your symptoms are
  • Whether you prefer infusion therapy in a clinic or injections at home
  • Your medical history and risk of side-effects
  • How you have responded to past treatments

Our healthcare team will guide you through the decision, ensuring the chosen biologic is safe, effective, and aligned with your lifestyle and health needs.

The Benefits of Infusion Therapy with Biologics

For many patients, infusion therapy offers important advantages:

  • Professional monitoring during treatment
  • Higher accuracy in dosing compared to self-injections
  • Longer intervals between treatments (weeks rather than days)
  • A controlled clinical environment for safety and comfort

Infliximab and Other Biologics: Making an Informed Decision

Both infliximab and other biologics have transformed the management of autoimmune diseases. Choosing the right option depends on your condition, preferences, and medical history. For many, infliximab remains a trusted first-line treatment, while others may benefit from newer biologics or biosimilars.

Infliximab Infusion Therapy at IV One Infusion Centre

At IV One Infusion Centre, we provide safe and effective infusion therapy for infliximab and other biologics. Our specialist team works with patients to create personalised treatment plans that maximise benefits while ensuring safety and comfort. Get in touch with us today to learn more about your options for biologic and intravenous therapy.

Frequently Asked Questions

1. How do I know if infliximab is the right biologic for me?

Your healthcare provider will assess your condition, symptoms, and history to determine whether infliximab or another biologic is most suitable.

Infliximab is given by infusion, while some biologics are given by injection. They also target slightly different immune pathways depending on the condition.

Infusion therapy offers precise dosing and professional supervision, while injections provide more flexibility at home. The right choice depends on patient preference and medical advice.

Yes, patients who do not respond well to infliximab may be switched to another biologic under medical guidance.

Yes, biosimilars of infliximab are available and provide equivalent safety and effectiveness at a lower cost.

Enquire Now